BAP1 and metastatic neoplasm: There has been increasing attention on the impact of activating genetic mutations in GNAQ and GNA11, loss-of-function mutations in the tumor suppressor gene BAP1, and recurrent mutations at codon 625 of SF3B1 on the advancement of UM towards metastatic disease [8].